Cell‐type‐specific gene expression and regulation in the cerebral cortex and kidney of atypical Setbp1 S858R Schinzel Giedion Syndrome mice
Journal of Cellular and Molecular Medicine · 2023
DOI: 10.1111/jcmm.18001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Jordan H Whitlock und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama,…. Hauptthemen laut MEDLINE: Abnormalities, Multiple. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Schinzel Giedion Syndrome (SGS) is an ultra‐rare autosomal dominant Mendelian disease presenting with abnormalities spanning multiple organ systems. The most notable phenotypes involve severe developmental delay, progressive brain atrophy, and drug‐resistant seizures. SGS is caused by spontaneous variants in SETBP1 , which encodes for the epigenetic hub SETBP1 transcription factor (TF). SETBP1 variants causing classical SGS cluster at the degron, disrupting SETBP1 protein degradation and resulting in toxic accumulation, while those located outside cause milder atypical SGS. Due to the multisystem phenotype, we evaluated gene expression and regulatory programs altered in atypical SGS by snRNA‐seq of the cerebral cortex and kidney of Setbp1 S858R heterozygous mice (corresponds to the human likely pathogenic SETBP1 S867R variant) compared to matched wild‐type mice by constructing cell‐type‐specific regulatory networks. Setbp1 was differentially expressed in excitatory neurons, but known SETBP1 targets were differentially expressed and regulated in many cell types. Our findings suggest molecular drivers underlying neurodevelopmental phenotypes in classical SGS also drive atypical SGS, persist after birth, and are present in the kidney. Our results indicate SETBP1's role as an epigenetic hub leads to cell‐type‐specific differences in TF activity, gene targeting, and regulatory rewiring. This research provides a framework for investigating cell‐type‐specific variant impact on gene expression and regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cell, Developmental and Integrative Biology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
ORCID-Profile: Jordan H Whitlock, Tabea M Soelter, Timothy C Howton, Elizabeth J Wilk, Vishal H Oza, Brittany N Lasseigne
Förderung
- NIAID NIH HHS
- NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- NIH Office of the Director
Zitieren
APA
Whitlock, J. H., Soelter, T. M., Howton, T. C., Wilk, E. J., Oza, V. H., & Lasseigne, B. N. (2023). Cell‐type‐specific gene expression and regulation in the cerebral cortex and kidney of atypical Setbp1 S858R Schinzel Giedion Syndrome mice. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18001
Vancouver
Whitlock JH, Soelter TM, Howton TC, Wilk EJ, Oza VH, Lasseigne BN. Cell‐type‐specific gene expression and regulation in the cerebral cortex and kidney of atypical Setbp1 S858R Schinzel Giedion Syndrome mice. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.18001
BibTeX
@article{Whitlock2023,
author = {Whitlock, Jordan H and Soelter, Tabea M and Howton, Timothy C and Wilk, Elizabeth J and Oza, Vishal H and Lasseigne, Brittany N},
title = {Cell‐type‐specific gene expression and regulation in the cerebral cortex and kidney of atypical Setbp1 S858R Schinzel Giedion Syndrome mice},
journal = {Journal of Cellular and Molecular Medicine},
year = {2023},
doi = {10.1111/jcmm.18001}
}
EUVIMED